This book, written by a team of leading experts, provides a
comprehensive overview of acute myeloid leukemia (AML), the most
frequent acute leukemia in adults. The opening chapters present
current knowledge of epidemiology, etiologic factors, and the
pathogenesis and molecular development of AML. Detailed guidance is
offered on laboratory and clinical diagnostic workup and disease
classification, and the patient- and disease-related factors that
determine prognosis and treatment allocation are identified. On the
basis of these general considerations, initial treatments in
patients considered fit for intensive treatment and in older and
co-morbid patients are reviewed, and the available relapse
treatment strategies, explained. For all clinical scenarios, the
most recent data on the optimal use of newly approved agents in
different AML subgroups are presented. Separate chapters address
the treatment of acute promyelocytic leukemia, current practice of
allogeneic stem cell transplantation, and special clinical
situations. Finally, promising approaches in drug development,
current standards and challenges in assessment of measurable
residual disease, immune approaches, and ideas for innovative trial
designs are considered.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!